Document is current
Any future updates will be listed below
-
Authors
Sunzenauer, Judith
Rammer, Melanie
Stöckl, Leonhard
Lugmayr, Lisa
Binder, Viktoria
Strauss, Eva
Priglinger, Katharina
Pernsteiner, Victoria
Kehrer, Helmut
Theander, Thor Grundtvig
Schröcksnadel, Peter
Webersinke, Gerald
Salanti, Ali
Agerbæk, Mette Ørskov
Sepp, Norbert
- License Information
-
More Information
Article History
Received: 30 September 2025
Accepted: 10 February 2026
First Online: 20 February 2026
Declarations
:
: H.K. is consultant for MSD, Bristol Myers Squibb and Pierre Fabre. The aforementioned functions are unrelated to the research presented in this manuscript. The technology to diagnose cancer through rVAR2 is owned by VarCT Diagnostics through a license from VAR2Pharmaceuticals. A.S., T.G.T., M.Ø.A. and P.S. are cofounders of VAR2Pharmaceuticals. The other authors declare no competing interest.
